AJP - Renal Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 280: F231-F238, 2001;
0363-6127/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiyama, A.
Right arrow Articles by Abe, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiyama, A.
Right arrow Articles by Abe, Y.
Vol. 280, Issue 2, F231-F238, February 2001

Renal interstitial adenosine metabolism during ischemia in dogs

Akira Nishiyama1, Shoji Kimura1, Hong He1, Katsuyuki Miura2, Matlubur Rahman1, Yoshihide Fujisawa3, Toshiki Fukui1, and Youichi Abe1

1 Department of Pharmacology and 3 Research Equipment Center, Kagawa Medical University, Kagawa 761-0793; and 2 Department of Pharmacology, Osaka City University Medical School, Osaka 545-8585, Japan

The present study was conducted to determine the metabolism of renal interstitial adenosine under resting conditions and during ischemia. By using a microdialysis method with HPLC-fluorometric analysis, renal interstitial concentrations of adenosine, inosine, and hypoxanthine were assessed in pentobarbital-anesthetized dogs. Average basal renal interstitial concentrations of adenosine, inosine, and hypoxanthine were 0.18 ± 0.04, 0.31 ± 0.05, and 0.35 ± 0.05 µmol/l, respectively. Local inhibition of adenosine kinase with iodotubercidin (10 µmol/l in perfusate) or inhibition of adenosine deaminase with erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA; 100 µmol/l in perfusate) did not change adenosine concentrations in the nonischemic kidneys (0.18 ± 0.04 and 0.24 ± 0.05 µmol/l, respectively). On the other hand, treatment with iodotubercidin+EHNA significantly increased adenosine concentration (0.52 ± 0.07 µmol/l) with significant decreases in inosine and hypoxanthine levels (0.13 ± 0.03 and 0.19 ± 0.04 µmol/l, respectively). During 30 min of ischemia, adenosine, inosine, and hypoxanthine were significantly increased to 0.76 ± 0.29, 2.14 ± 0.45, and 21.8 ± 4.7 µmol/l, respectively. The treatment with iodotubercidin did not alter ischemia-induced increase in adenosine (0.84 ± 0.18 µmol/l); however, EHNA alone markedly enhanced adenosine accumulation (13.54 ± 2.16 µmol/l), the value of which was not augmented by an addition of iodotubercidin (15.80 ± 1.24 µmol/l). In contrast, ischemia-induced increases in inosine and hypoxanthine were inversely diminished by the treatment with iodotubercidin+EHNA (0.90 ± 0.20 and 9.86 ± 1.96 µmol/l, respectively). These results suggest that both adenosine kinase and adenosine deaminase contribute to the metabolism of renal interstitial adenosine under resting conditions, whereas adenosine produced during ischemia is mainly metabolized by adenosine deaminase and the rephosphorylation of adenosine by adenosine kinase is small.

renal interstitium; adenosine deaminase; adenosine kinase


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Franco, R. Bautista, O. Perez-Mendez, L. Gonzalez, U. Pacheco, L. G. Sanchez-Lozada, J. Santamaria, E. Tapia, R. Monreal, and F. Martinez
Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F84 - F92.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P. B. Hansen and J. Schnermann
Vasoconstrictor and vasodilator effects of adenosine in the kidney
Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Aki, A. Nishiyama, A. Miyatake, S. Kimura, M. Kohno, and Y. Abe
Role of Adenosine A1 Receptor in Angiotensin II- and Norepinephrine-Induced Renal Vasoconstriction
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 117 - 123.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Nishiyama, D. M. Seth, and L. G. Navar
Renal Interstitial Fluid Concentrations of Angiotensins I and II in Anesthetized Rats
Hypertension, January 1, 2002; 39(1): 129 - 134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y.-F. Chen, P.-L. Li, and A.-P. Zou
Oxidative stress enhances the production and actions of adenosine in the kidney
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1808 - R1816.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online